Additionally, LBP could stimulate the p38 MAPK signaling pathway and counteract the inflammatory response (e.g., reducing IL-6 and ICAM-1 levels) and OS (e.g., enhancing SOD and GSH-Px activities), alleviating the DM-induced vascular lesions (112). Here, IL6 is linked to diabetes mellitus.